GW Pharma's Guy sells to Whittle

Geoffrey Guy, executive chairman of GW Pharmaceuticals, has sold almost £600,000 of shares in the cannabis-based medicine firm to co-founder Brian Whittle.

The purchase of 750,000 shares from Guy at 79p each cost Whittle, who retired as a director at GW last year, £592,500.

Whittle and Guy set up the company in 1998 and listed it on the London Stock Exchange in June 2001.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Guy also gifted, for nil consideration, a further 782,111 shares to Whittle and members of Whittle's family.

Despite transferring over 1.5m shares, or 1.3% of the business, Guy still owns a 15.2% stake.

GW posted a maiden annual profit last month. It made £4m on revenue up to £16.1m from £5.7m thanks to increased sales and milestone revenue from Almirall and Sativax

Top Director Buys

Value: £129,366

Value: £53,480

Value: £35,340

Value: £24,878

Value: £24,878

Value: £22,825

Value: £19,902

Value: £11,750

Value: £11,600

Value: £10,536

Top Director Sells

Value: £592,500